Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

327.64 +0.33 (+0.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2 3 4 5 6 7 8 9

...

62 63 Next >

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

October 31, 2025

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

Via TokenRing AI

Topics Artificial Intelligence Supply Chain

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

October 31, 2025

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence Economy

Price Over Earnings Overview: Amgen ↗

October 17, 2025

Via Benzinga

How Royalty Pharma Prints Cash Without Biotech's Biggest Risks ↗

October 31, 2025

Via MarketBeat

Marjorie Taylor Greene Buys Netflix Stock After Downbeat Q3 Earnings, Expands Big Tech Bet ↗

October 31, 2025

MTG "buys the dip" on Netflix (NFLX) stock after a bad Q3 report. See all 14 of her new purchases, including MSFT and AMZN.

Via Benzinga

Marjorie Taylor Greene Buys 6 Stocks: Buffett, Health Care — And This Magnificent 7 Stock ↗

October 29, 2025

Marjorie Taylor Greene discloses buying more stocks in October. Here's a look at what she added to her portfolio.

Via Benzinga

S&P 500 Healthcare Sector Navigates Mixed Market Waters on October 29, 2025

October 29, 2025

On October 29, 2025, the broader market exhibited a decidedly mixed performance, reflecting a prevailing sense of uncertainty among investors. Against this backdrop of fluctuating sentiment, the S&P...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

What Does the Market Think About Amgen Inc? ↗

October 27, 2025

Via Benzinga

2 Value Stocks on Our Watchlist and 1 Facing Headwinds

October 27, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

Topics Artificial Intelligence

Biogen's Immunology Pipeline Has Long-Term Potential: Analyst ↗

October 24, 2025

Biogen gains exclusive rights to Vanqua's oral C5aR1 antagonist, boosting its immunology pipeline with potential across multiple immune diseases.

Via Benzinga

1 Top Dividend Growth Stock to Buy Right Now ↗

October 24, 2025

Its shares might not remain undervalued for that much longer.

Via The Motley Fool

Topics Economy Government Intellectual Property

Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 22, 2025

From Halper Sadeh LLC

Via Business Wire

Market Minute: Dow Soars, Apple Hits Record High as 20-Day Government Shutdown Fuels Gold Rally

October 20, 2025

The U.S. financial markets opened the week with a robust performance on October 20, 2025, as the Dow Jones Industrial Average (DJIA) extended its gains, and tech giant Apple Inc. (NASDAQ: AAPL) reached...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

2 Reasons to Like AMGN and 1 to Stay Skeptical

October 20, 2025

Although Amgen (currently trading at $299.86 per share) has gained 9.6% over the last six months, it has trailed the S&P 500’s 29.3% return during that period. This might have investors contemplating...

Via StockStory

Topics Stocks

United Therapeutics Forges Ahead with Share Repurchases, Not Dividends, Following July 2025 Volume Surge

October 17, 2025

In a financial landscape often fixated on consistent dividend payouts, United Therapeutics Corporation (NASDAQ: UTHR) stands out with a distinct capital allocation strategy. Contrary to market...

Via MarketMinute

Topics Retirement

Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs? ↗

October 17, 2025

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential impact on Eli Lilly and Pfizer.

Via Benzinga

Topics Government

Marjorie Taylor Greene, Cathie Wood Snap Up The Same 13 Stocks — Here's the Unlikely Portfolio Crossover ↗

October 16, 2025

A look at the stock owned by both Ark Funds and Congresswoman Marjorie Taylor Greene.

Via Benzinga

Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity ↗

October 16, 2025

William Blair assigns Climb Bio an Outperform rating, projecting peak sales of $1.9 billion and long-term growth for its therapy pipeline.

Via Benzinga

Dow Jones Stumbles with Fractional Dip, Signaling Cautious Market Sentiment Amidst Global Headwinds

October 15, 2025

New York, NY – October 15, 2025 – The Dow Jones Industrial Average (DJIA) experienced a fractional dip today, reflecting a palpable sense of caution pervading market sentiment. While other major...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Reflecting On Therapeutics Stocks’ Q2 Earnings: Amgen (NASDAQ:AMGN)

October 12, 2025

Looking back on therapeutics stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Amgen (NASDAQ:AMGN) and its peers.

Via StockStory

Topics Artificial Intelligence

Trump Plans AstraZeneca Deal To Cut Drug Prices For Low-Income Americans ↗

October 10, 2025

Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing model.

Via Benzinga

Topics Government

Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch ↗

October 09, 2025

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers.

Via Benzinga

Topics Government

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

2 S&P 500 Stocks to Target This Week and 1 Facing Challenges

October 08, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

Martin Capital Buys Into Portland General Electric’s Defensive Power Play ↗

October 07, 2025

Via The Motley Fool

Topics Energy Regulatory Compliance

Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices ↗

October 06, 2025

Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrictions.

Via Benzinga

Topics Government

Martin Capital Dumps $3.0 Million Worth of LyondellBasell Industries Stock ↗

October 06, 2025

Via The Motley Fool

Topics Energy

Martin Capital Liquidates its Diageo Position: What That Means for the Alcoholic Beverages Titan ↗

October 06, 2025

Via The Motley Fool

Martin Capital Exits $5.8 Million Comcast Stake as Broadband Challenges Persist ↗

October 06, 2025

Via The Motley Fool

Martin Capital Sells $3.6 Million in JPMorgan Stock — What to Know Ahead of Q3 Earnings ↗

October 06, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

62 63 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.